Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks

Cell-penetrating peptides (CPPs), and metal-organic frameworks (MOFs) are promising as next-generation for the delivery of gene-based therapeutic agents. Oligonucleotide (ON)-mediated assembly of nanostructures composed of hierarchical porous zeolitic imidazolate framework (ZIF-8), and nanoparticles...

Full description

Saved in:
Bibliographic Details
Published inMicroporous and mesoporous materials Vol. 300; p. 110173
Main Authors Abdelhamid, Hani Nasser, Dowaidar, Moataz, Hällbrink, Mattias, Langel, Ülo
Format Journal Article
LanguageEnglish
Published Elsevier Inc 15.06.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cell-penetrating peptides (CPPs), and metal-organic frameworks (MOFs) are promising as next-generation for the delivery of gene-based therapeutic agents. Oligonucleotide (ON)-mediated assembly of nanostructures composed of hierarchical porous zeolitic imidazolate framework (ZIF-8), and nanoparticles such as graphene oxide (GO), and magnetic nanoparticles (MNPs) for gene therapy are reported. Five different types of non-viral vectors (ZIF-8, RhB@ZIF-8, BSA@ZIF-8, MNPs@ZIF-8, and GO@ZIF-8), and three gene therapeutic agents (plasmid, splice correction oligonucleotides (SCO), and small interfering RNA (siRNA)) were investigated. The polyplexes were characterized and applied for gene transfection. The materials show very low toxicity with high efficiency for luciferase transfection. ZIF-8 enhances the transfection of plasmid, SCO, siRNA of CPPs by 2–8 folds. The mechanism of the cell uptakes was also highlighted. Data reveal cell internalization via scavenger class A (SCARA). [Display omitted] •Synthesis of hierarchical porous zeolitic imidazolate frameworks.•Synthesis of ZIF-8 composite with nanoparticles.•Investigate ZIF-8 and their composite for gene delivery.•Explore reasonable mechanism of cell uptake for oligonucleotides@ZIF-8.
ISSN:1387-1811
1873-3093
1873-3093
DOI:10.1016/j.micromeso.2020.110173